Meropenem is a broad spectrum antibiotic that has been approved to treat other complicated intra-abdominal infections and complicated skin infections in older children and adults and for treating children under 3 months old for bacterial meningitis.
The approval came after NIH researchers performed a study to evaluate the dosing and safety of using the drug on infants who had complicated intra-abdominal infections. The study determined the antibiotic was safe to use in very young infants and was not associated with increased risk for serious side effects. The study also determined appropriate dosing.
More articles on antibiotics:
Diagnostic errors tied to overuse of antibiotics
Mystery of bacterial infection and heart complications solved
11 recent stories on antibiotics and drug resistance
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
